Shukra Pharmaceuticals has informed that the meeting of the Board of Directors of the Company will be held on November 14, 2016 inter alia, to consider, adopt and approve Unaudited Financial Results for the quarter ended on September 30, 2016.
Further, as per the Company’s Code of Conduct for Prohibition of Insider Trading, the trading window for dealing in the securities of the Company will be closed for all specified persons of the Company from November 07, 2016 to November 16, 2016 both days inclusive.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1620.80 |
| Dr. Reddys Lab | 1317.95 |
| Cipla | 1280.00 |
| Zydus Lifesciences | 929.20 |
| Lupin | 2270.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: